Search Results

There are 3574 results for: content related to: A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

  1. Reaching glycaemic targets while minimizing hypoglycaemia in insulin-treated type 2 diabetes patients

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 14–23, C. Mathieu and S. Robbrecht

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00841.x

  2. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Karl Horvath, Klaus Jeitler, Andrea Berghold, Susanne H Ebrahim, Thomas W Gratzer, Johannes Plank, Thomas Kaiser, Thomas R Pieber and Andrea Siebenhofer

    Published Online : 18 APR 2007, DOI: 10.1002/14651858.CD005613.pub3

  3. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 50–65, C. Bradley and C. J. B. Gilbride

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00871.x

  4. You have full text access to this OnlineOpen article
    A randomized trial comparing the rate of hypoglycemia—assessed using continuous glucose monitoring—in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study)

    Pediatric Diabetes

    Volume 14, Issue 8, December 2013, Pages: 593–601, Thomas Danne, Areti Philotheou, David Goldman, Xiang Guo, Lin Ping, Anna Cali and Peter Johnston

    Version of Record online : 3 JUN 2013, DOI: 10.1111/pedi.12051

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 16, Issue 6, 462, Version of Record online: 11 AUG 2015

  5. You have full text access to this OnlineOpen article
    Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain

    International Journal of Clinical Practice

    Volume 66, Issue 3, March 2012, Pages: 281–288, E. Delgado and on behalf of LAUREL Spain study investigators

    Version of Record online : 16 FEB 2012, DOI: 10.1111/j.1742-1241.2011.02880.x

  6. Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1085–1092, G. E. Dailey, L. Gao, L. Aurand and S. K. Garg

    Version of Record online : 12 JUN 2013, DOI: 10.1111/dom.12131

  7. Insulin detemir versus insulin glargine for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Sanne G Swinnen, Airin CR Simon, Frits Holleman, Joost B Hoekstra and J Hans DeVries

    Published Online : 6 JUL 2011, DOI: 10.1002/14651858.CD006383.pub2

  8. The cost-effectiveness of insulin glargine vs. neutral protamine Hagedorn insulin in type 2 diabetes: a focus on health economics

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 66–75, P. Levin

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00845.x

  9. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

    Diabetes, Obesity and Metabolism

    Volume 9, Issue 5, September 2007, Pages: 648–659, T. Heise and T. R. Pieber

    Version of Record online : 21 JUL 2007, DOI: 10.1111/j.1463-1326.2007.00756.x

  10. Safety and efficacy of insulin glargine (HOE 901) versus NPH insulin in combination with oral treatment in Type 2 diabetic patients

    Diabetic Medicine

    Volume 20, Issue 7, July 2003, Pages: 545–551, HOE 901/2004 Study Investigators Group

    Version of Record online : 27 JUN 2003, DOI: 10.1046/j.1464-5491.2003.00999.x

  11. Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 8, August 2011, Pages: 711–717, G. G. Rhoads, M. P. Dain, Q. Zhang and L. Kennedy

    Version of Record online : 21 JUN 2011, DOI: 10.1111/j.1463-1326.2011.01394.x

  12. Basal insulin switch from NPH to glargine in children and adolescents with type 1 diabetes

    Pediatric Diabetes

    Volume 9, Issue 3pt2, June 2008, Pages: 83–90, Minna Päivärinta, Päivi Tapanainen and Riitta Veijola

    Version of Record online : 25 JAN 2008, DOI: 10.1111/j.1399-5448.2007.00341.x

  13. Initiation of insulin glargine in children and adolescents with type 1 diabetes

    Pediatric Diabetes

    Volume 5, Issue 2, June 2004, Pages: 80–86, Chin Yao Tan, Darrell M. Wilson and Bruce Buckingham

    Version of Record online : 9 JUN 2004, DOI: 10.1111/j.1399-543X.2004.00039.x

  14. You have full text access to this OnlineOpen article
    Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 17, Issue 1, January 2015, Pages: 15–22, P. D. Home, G. B. Bolli, C. Mathieu, C. Deerochanawong, W. Landgraf, C. Candelas, V. Pilorget, M.-P. Dain and M. C. Riddle

    Version of Record online : 12 JUL 2014, DOI: 10.1111/dom.12329

  15. The past, present, and future of basal insulins

    Diabetes/Metabolism Research and Reviews

    Volume 32, Issue 6, September 2016, Pages: 478–496, Jeremy Pettus, Tricia Santos Cavaiola, William V. Tamborlane and Steven Edelman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/dmrr.2763

  16. A review of basal insulins

    Diabetic Medicine

    Volume 20, Issue 11, November 2003, Pages: 873–885, Anthony H. Barnett

    Version of Record online : 22 OCT 2003, DOI: 10.1046/j.1464-5491.2003.00996.x

  17. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 9, September 2010, Pages: 772–779, P. D. Home, A. Fritsche, S. Schinzel and M. Massi-Benedetti

    Version of Record online : 23 APR 2010, DOI: 10.1111/j.1463-1326.2010.01232.x

  18. An overview of insulin glargine

    Diabetes/Metabolism Research and Reviews

    Volume 18, Issue S3, September/October 2002, Pages: S57–S63, Philip D. Home and Simon G. Ashwell

    Version of Record online : 24 SEP 2002, DOI: 10.1002/dmrr.317

  19. Old and new basal insulin formulations: understanding pharmacodynamics is still relevant in clinical practice

    Diabetes, Obesity and Metabolism

    Volume 16, Issue 8, August 2014, Pages: 695–706, P. Rossetti, F. J. Ampudia-Blasco and J. F. Ascaso

    Version of Record online : 9 FEB 2014, DOI: 10.1111/dom.12256

  20. Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience

    Diabetes, Obesity and Metabolism

    Volume 10, Issue s2, July 2008, Pages: 24–34, S. A. Schreiber

    Version of Record online : 10 JUN 2008, DOI: 10.1111/j.1463-1326.2008.00842.x